Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
1. Develop a wearable sensor package to gather data on COVID-19-like signs and symptoms such as elevated body temperature, respiratory parameters, heart rate ,cough and gait. 2. Create algorithms to monitor and track changes to COVID19-like signs and symptoms for developing a better care and isolation strategies for COVID-19 pandemic.
Description: Body temperature : Periodic temperature readings over the day (every 15 minutes)
Measure: Body temperature Time: Minimum 7 days from day 1 of study enrollment up to 60 daysDescription: Number of coughing episodes in an hour
Measure: Cough Frequency Time: Minimum 7 days from day 1 of study enrollment up to 60 daysDescription: Number of breaths per minute
Measure: Respiratory frequency Time: Minimum 7 days from day 1 of study enrollment up to 60 daysDescription: Instantaneous heart rate every 15 minutes
Measure: Heart Rate Instantaneous heart rate every 15 minutes. Time: Minimum 7 days from day 1 of study enrollment up to 60 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports